EUVIMEDEUVIMED entdecken
Crossref

Pyrimidine–triazole‐tethered tert ‐butyl‐piperazine‐carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β‐catenin activation

Jie Yuan iD, Li Yang, Zhi Li, Hua Zhang, Qun Wang, Bei Wang, Arunachalam Chinnathambi, Chandramohan Govindasamy, Shreeja Basappa, Omantheswara Nagaraja, Mahendra Madegowda, Narasimha M Beeraka iD und 5 weitere

IUBMB Life · 2024

DOI: 10.1002/iub.2913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2024. Verfasst von Jie Yuan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast, Thyroid and Vascular Surgery, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taih…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cell Proliferation, Triazoles, beta Catenin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Hubei Provincial Department of Education Research Plan Guidance Project, King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several chemotherapeutics against breast cancer are constrained by their adverse effects and chemoresistance. The development of novel chemotherapeutics to target metastatic breast cancer can bring effective clinical outcomes. Many breast cancer patients present with tumors that are positive for estrogen receptors (ERs), highlighting the importance of targeting the ER pathway in this particular subtype. Although selective estrogen receptor modulators (SERMs) are commonly used, their side effects and resistance issues necessitate the development of new ER‐targeting agents. In this study, we report that a newly synthesized compound, TTP‐5, a hybrid of pyrimidine, triazole, and tert ‐butyl‐piperazine‐carboxylate, effectively binds to estrogen receptor alpha (ERα) and suppresses breast cancer cell growth. We assessed the impact of TTP‐5 on cell proliferation using MTT and colony formation assays and evaluated its effect on cell motility through wound healing and invasion assays. We further explored the mechanism of action of this novel compound by detecting protein expression changes using Western blotting. Molecular docking was used to confirm the interaction of TTP‐5 with ERα. The results indicated that TTP‐5 significantly reduced the proliferation of MCF‐7 cells by blocking the ERα signaling pathway. Conversely, although it did not influence the growth of MDA‐MB‐231 cells, TTP‐5 hindered their motility by modulating the expression of proteins associated with epithelial–mesenchymal transition (EMT), possibly via the Wnt/β‐catenin pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCell ProliferationTriazolesbeta CateninPyrimidinesEstrogen Receptor alphaCell MovementMolecular Docking SimulationSignal TransductionHumansFemaleMCF-7 CellsGene Expression Regulation, NeoplasticPiperazinesAntineoplastic AgentsApoptosis

Stichwörter der Autor:innen

EMTER signaling pathwayTTP‐5breast cancerβ‐catenin

Substanzen

Triazolesbeta CateninPyrimidinesEstrogen Receptor alphaESR1 protein, humanCTNNB1 protein, humanPiperazinespyrimidineAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Breast, Thyroid and Vascular Surgery, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Department of Clinical Laboratory Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
  • Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
  • Department of Chemistry, BITS-Pilani, Hyderabad Campus, Medchal, India.
  • Department of Studies in Physics, University of Mysore, Mysore, India.

ORCID-Profile: Jie Yuan, Narasimha M Beeraka

Förderung

  • Hubei Provincial Department of Education Research Plan Guidance Project
  • King Saud University

Zitieren

APA

Yuan, J., Yang, L., Li, Z., Zhang, H., Wang, Q., Wang, B., Chinnathambi, A., Govindasamy, C., Basappa, S., Nagaraja, O., Madegowda, M., Beeraka, N. M., Nikolenko, V. N., Wang, M., Wang, G., Rangappa, K. S., & Basappa, B. (2024). Pyrimidine–triazole‐tethered tert ‐butyl‐piperazine‐carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β‐catenin activation. IUBMB Life. https://doi.org/10.1002/iub.2913

Vancouver

Yuan J, Yang L, Li Z, Zhang H, Wang Q, Wang B, et al. Pyrimidine–triazole‐tethered tert ‐butyl‐piperazine‐carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β‐catenin activation. IUBMB Life. 2024. doi:10.1002/iub.2913

BibTeX
@article{Yuan2024,
  author = {Yuan, Jie and Yang, Li and Li, Zhi and Zhang, Hua and Wang, Qun and Wang, Bei and Chinnathambi, Arunachalam and Govindasamy, Chandramohan and Basappa, Shreeja and Nagaraja, Omantheswara and Madegowda, Mahendra and Beeraka, Narasimha M and Nikolenko, Vladimir N and Wang, Minghua and Wang, Geng and Rangappa, Kanchugarakoppal S and Basappa, Basappa},
  title = {Pyrimidine–triazole‐tethered tert ‐butyl‐piperazine‐carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β‐catenin activation},
  journal = {IUBMB Life},
  year = {2024},
  doi = {10.1002/iub.2913}
}
Kostenlos starten →